SM-102
CAS No. 2089251-47-6
SM-102( —— )
Catalog No. M28671 CAS No. 2089251-47-6
SM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 113 | In Stock |
|
| 10MG | 167 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 444 | In Stock |
|
| 100MG | 615 | In Stock |
|
| 200MG | 876 | In Stock |
|
| 500MG | 1305 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSM-102
-
NoteResearch use only, not for human use.
-
Brief DescriptionSM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.
-
DescriptionSM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2089251-47-6
-
Formula Weight710.17
-
Molecular FormulaC44H87NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : ≥ 100 mg/mL (140.81)
-
SMILESCCCCCCCCCCCOC(CCCCCN(CCCCCCCC(OC(CCCCCCCC)CCCCCCCC)=O)CCO)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.WO/2005/121087A1
molnova catalog
related products
-
Astragenol
Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.
-
Lumazine
Lumazine is a new MALDI matrix for complex (phospho)lipid mixtures analysis.
-
Amylin (IAPP), felin...
Amylin (IAPP), feline is the peptide subunit of amyloid found in pancreatic islets of type 2 diabetic patients and in insulinomas.
Cart
sales@molnova.com